Online citations, reference lists, and bibliographies.

Elderly And Drugs: Risks And Necessity Of Rational Use

André Oliveira Baldoni, Farah Maria Drumond Chequer, Elisa Raquel Anastácio Ferraz, Danielle Palma de Oliveira, Leonardo Régis Leira Pereira, Daniel Junqueira Dorta
Published 2010 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
Share
In recent decades, the world has undergone a demographic transformation with a rapid growth of the elderly population, resulting in an increased demand for funds to maintain their health and drug consumption. Pharmacokinetic and pharmacodynamic changes occurring in the elderly can interfere directly in the adverse effects of drugs and increase the risk of intoxication. In addition, there are external factors interfering with the pharmacotherapy of the elderly, such as inappropriate use and the lack of access to information. Many therapeutic classes of drugs should be used with caution or avoided in the elderly population, such as anti-inflammatory and some anti-hypertensive drugs, diuretics and digitalis. If not managed carefully, these medicines can affect the safety and quality of life in the elderly. Thus, the aim of this review was to identify drugs that should be used with caution in elderly patients in order to avoid intoxication and/or adverse drug events.
This paper references
10.1111/j.1532-5415.2000.tb04782.x
Sedative, hypnotic, and antianxiety medication use in an aging cohort over ten years: a racial comparison.
D. Blazer (2000)
10.1016/S0306-3623(97)00070-0
Antidepressant drugs in the elderly.
Pietro Gareri (1998)
10.3322/canjclin.47.1.5
Cancer statistics, 1997.
S L Parker (1997)
10.2165/00002512-200724050-00004
Oral Anticancer Drugs in the Elderly
Sara Lonardi (2007)
10.1016/S1543-5946(04)90015-3
Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly.
Rajender Aparasu (2004)
10.1016/S0924-977X(03)92209-7
P.4.014 Correlation of depressive symptoms and cognitive decline in elderly people
I. -K. Jung (2003)
10.2165/00002018-200932020-00004
Treating Hypertension in Older Adults
Wilbert S Aronow (2009)
10.1016/0163-7258(94)90066-3
Age, environmental factors and drug metabolism.
M. S. O’mahony (1994)
10.1111/j.1365-2125.1988.tb03391.x
Suspected adverse drug reactions in elderly patients reported to the Committee on Safety of Medicines.
C. Mark Castleden (1988)
10.1046/j.1532-5415.2001.49262.x
Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada.
Karen Tu (2001)
10.1136/bmj.310.6971.25
Antiplatelet treatment in elderly people with transient ischaemic attacks or ischaemic strokes
Juhani Sivenius (1995)
10.2165/00002512-199202010-00004
Salicylate Intoxication in the Elderly
C Durnas (1992)
10.2165/00002512-200320020-00005
Drug Treatment of Epilepsy in Elderly People
L. Stephen (2003)
10.1002/(SICI)1099-1166(199904)14:4<280::AID-GPS898>3.0.CO;2-O
Benzodiazepine use among the elderly in the community.
M Kirby (1999)
[Drug therapy of elderly patients].
G Galeotta (1990)
10.1001/JAMA.298.22.2634
Thiazolidinediones and cardiovascular outcomes in older patients with diabetes.
L. Lipscombe (2007)
10.2165/00003088-198917060-00003
Clinical Pharmacokinetics of Antibacterial Drugs in the Elderly
Burt R. Meyers (1989)
10.1016/S1525-8610(04)70082-1
Antibiotic prescribing and outcomes following treatment of symptomatic urinary tract infections in older women.
Paul Y. Takahashi (2002)
Prostate cancer in the elderly.
Konstantinos N. Syrigos (2005)
Epidemiology and diagnosis of depression in late life.
Benoit H. Mulsant (1999)
10.2165/00002512-199813050-00003
Drug Dosage in the Elderly
K. Turnheim (1998)
10.1016/S0002-9149(03)00530-7
Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial).
P. Jones (2003)
10.1016/j.gtc.2009.06.011
Pharmacologic consideration of commonly used gastrointestinal drugs in the elderly.
Barbara J Zarowitz (2009)
Recognition and treatment of depression in the elderly.
Gary W. Small (1991)
10.1097/00131746-200511001-00002
Introduction: Methods, Commentary, and Summary
Michael H. Allen (2004)
10.1136/bmj.2.5711.705
Maintenance Digoxin in Elderly Patients
John L. C. Dall (1970)
10.1001/jama.296.24.2947
Long-term proton pump inhibitor therapy and risk of hip fracture.
Yu-Xiao Yang (2006)
10.1016/j.critrevonc.2008.07.017
Taxanes in the elderly: can we gain as much and be less toxic?
Laura Biganzoli (2009)
10.2165/00002512-199404040-00006
Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders.
Malini Haria (1994)
10.1111/j.1464-410X.2007.06915.x
Analysis of the efficacy and safety of sildenafil citrate in the geriatric population.
Alexander Mueller (2007)
10.1016/S1040-8428(00)00109-8
Cancer and age in the USA.
L. Balducci (2001)
10.1590/S1516-93322005000200016
Pattern of drugs prescribed for community-residing middle-aged and older adults from the outskirts of Brasília
Otávio Toledo Nóbrega (2005)
10.1016/j.pnpbp.2009.04.023
Dosing of antipsychotics in schizophrenia across the life-spectrum
Hiroyuki Uchida (2009)
10.2147/VHRM.S4053
Safety and efficacy of rosiglitazone in the elderly diabetic patient
Adie Viljoen (2009)
10.1001/archfami.7.3.274
Treatment of depression in elderly patients: recent advances.
K. Dasgupta (1998)
Pharmacokinetics and drug toxicity in elderly patients: a case for geriatric core data in clinical trials.
P Ritz (2007)
10.1016/j.amjopharm.2005.09.014
Update on drug-induced depression in the elderly.
Michael Kotlyar (2005)
10.1093/geronj/46.6.P372
Imipramine in the treatment of depressed Alzheimer's patients: impact on cognition.
Linda Teri (1991)
10.1056/NEJM198205063061804
Drug disposition in old age.
David J Greenblatt (1982)
10.1016/S0531-5565(03)00133-5
When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly
K. Turnheim (2003)
Guidelines for treatment of hypertension in the elderly--2002 revised version.
Toshio Ogihara (2003)
10.1016/j.amjcard.2008.10.029
Comparison of efficacy and safety of atorvastatin (80 mg) to simvastatin (20 to 40 mg) in patients aged <65 versus >or=65 years with coronary heart disease (from the Incremental DEcrease through Aggressive Lipid Lowering [IDEAL] study).
Matti Tikkanen (2009)
10.1056/NEJM198204223061603
Cardiovascular effects of tricyclic antidepressants in depressed patients with chronic heart disease.
R. Veith (1982)
10.7326/0003-4819-114-4-257
Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons.
M. Griffin (1991)
10.2190/UHL6-0X4W-FRNG-8PFF
Antidepressant Drug Therapy in the Elderly: Enhancing Safety and Compliance
Antony Halaris (1986)
10.1159/000089825
Pharmacokinetics of Fluoxetine in Elderly Men and Women
James M. Ferguson (2006)
Development and validation of an improved prescribing in the elderly
NAUGLER (2000)
10.1016/0736-4679(96)00035-2
Antibiotic use in the emergency department. II The aminoglycosides, macrolides, tetracyclines, sulfa drugs, and urinary antiseptics.
Kimberlie A. Graeme (1996)
Drug dosage in the elderly . Is it rational ?
K. TURNHEIM (1998)
10.1046/j.1365-2710.1998.00164.x
In vivo age-related changes in hepatic drug-oxidizing capacity in humans.
E. Tanaka (1998)
10.1016/S0301-0082(99)00050-7
Conventional and new antidepressant drugs in the elderly
Pietro Gareri (2000)
10.1161/CIRCULATIONAHA.106.654756
Effects of Intensive Versus Moderate Lipid-Lowering Therapy on Myocardial Ischemia in Older Patients With Coronary Heart Disease: Results of the Study Assessing Goals in the Elderly (SAGE)
Prakash C. Deedwania (2007)
10.1016/j.exger.2004.05.011
Drug therapy in the elderly
Klaus Turnheim (2004)
10.2500/108854100778249033
Safety of second generation antihistamines.
Edward E. Philpot (2000)
10.1016/j.ijantimicag.2005.10.015
Antibiotic treatment and resistance of unselected uropathogens in the elderly.
Sita Nys (2006)
10.1111/j.1528-1167.2006.00585.x
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes.
T. Glauser (2006)
10.1111/j.1365-2125.1977.tb00694.x
Age as a factor affecting lithium therapy.
D. Hewick (1977)
10.1001/archfami.5.8.464
SAFETY OF ANTIHISTAMINES IN THE TREATMENT OF ALLERGIC RHINITIS IN ELDERLY PATIENTS
McCue Jd (1996)
10.1001/jama.1989.03430230088031
Benzodiazepines of long and short elimination half-life and the risk of hip fracture.
W. A. Ray (1989)
10.1016/0895-4356(96)00056-X
Age and severe adverse drug reactions caused by nifedipine and verapamil. Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA).
Marco Pahor (1996)
10.1177/104990910602300106
Use of methylphenidate in patients with cancer
A. Sood (2006)
Depressive disorders in older medical inpatients.
Harold G. Koenig (1991)
10.1093/gerona/62.8.879
Efficacy and safety of statin monotherapy in older adults: a meta-analysis.
Caroline G. P. Roberts (2007)
10.1111/j.1600-0447.1998.tb05973.x
Benzodiazepine dependence and withdrawal: a review of the syndrome and its clinical management.
E. Schweizer (1998)
Development and validation of an improving prescribing in the elderly tool.
C. Naugler (2000)
10.1517/14740330802423168
Paroxetine: safety and tolerability issues
D. M. Marks (2008)
10.1016/j.janxdis.2008.10.003
Benzodiazepine and antidepressant use in elderly patients with anxiety disorders: a survey of 796 outpatients in Japan.
Hiroyuki Uchida (2009)
10.1016/j.cger.2009.01.005
Polypharmacy in the elderly: focus on drug interactions and adherence in hypertension.
Danielle N. Cooney (2009)
Key references: Antiplatelet drugs in the elderly.
David Bonnell Green (2000)
10.1016/S0197-4572(96)80168-6
Salicylism in the elderly: "a little aspirin never hurt anybody"!
Nancy Fleming Courts (1996)
10.1136/pgmj.2003.017236
An approach to drug induced delirium in the elderly
K. Alagiakrishnan (2004)
10.1016/j.ctrv.2008.11.002
Head and neck cancer in the elderly: an overview on the treatment modalities.
K. Syrigos (2009)
10.2165/00002512-200522040-00005
Safety and Tolerability of Oral Erectile Dysfunction Treatments in the Elderly
A. Salonia (2005)
10.2165/00003495-199000391-00003
Ageing and its Effects on the Cardiovascular System
Michel E. Safar (2012)
Prevention of medication error and unintentional drug poisoning in the elderly.
Thomas Y. K. Chan (2006)
10.1016/j.amjopharm.2009.02.006
Methylphenidate for the treatment of depressive symptoms, including fatigue and apathy, in medically ill older adults and terminally ill adults.
Susan E. Hardy (2009)
Chronic salicylate intoxication.
Gittelman Dk (1993)
10.1016/S0899-9007(01)00555-X
Fat-free and fat mass percentiles in 5225 healthy subjects aged 15 to 98 years.
U. Kyle (2001)
10.1001/jama.1997.03550010041037
Benzodiazepine use and the risk of motor vehicle crash in the elderly.
B. Hemmelgarn (1997)
10.1192/bjp.181.5.406
Depressive symptoms and cognitive decline in elderly people. Longitudinal study.
Sabrina Paterniti (2002)
10.1097/00006842-197503000-00006
A Review of the Cardiovascular Effects and Toxicity of Tricyclic Antidepressants
James W. Jefferson (1975)
10.1111/j.1528-1157.1992.tb06225.x
Metabolism of antiepileptic medication: newborn to elderly.
Ilo E. Leppik (1992)
La terapia farmacologica nel paziente anziano
G. GALEOTTA (1990)
10.1016/j.cpcardiol.2008.10.002
Aldosterone and cardiovascular disease.
K. Gaddam (2009)
10.1056/NEJM198812293192604
Risk factors for falls among elderly persons living in the community.
M. Tinetti (1988)
Salicylate intoxication in the elderly. Recognition and recommendations on how to prevent it.
C Durnas (1992)
Lithium treatment and the geriatric population.
Len DeAngelis (1990)
10.1056/NEJM199106133242403
Sensitivity to triazolam in the elderly.
David J Greenblatt (1991)
10.1136/bmj.3.5880.582
Drug therapy in the elderly.
M. Penelope Hall (1973)
10.1016/S0026-0495(03)00298-1
Drug therapy in the elderly.
Rudolf E. Noble (2003)
10.1016/J.MPSUR.2012.01.006
Clinical pharmacology – the basics
John Jacob Posner (2009)
10.1016/0895-4356(96)00139-4
Predictors of chronic benzodiazepine use in a health maintenance organization sample.
G. Simon (1996)
10.1016/S0009-9236(98)90059-5
Benzodiazepine use and cognitive function among community-dwelling elderly.
J. Hanlon (1998)
10.1590/S1676-26492006000100004
Systemic and presystemic conversion of carbamazepine to carbamazepine-10,11-epoxide during long term treatment
Pietro Fagiolino (2006)
10.2165/00002512-200522030-00001
Cyclo-Oxygenase-2 Inhibitors
Ruth L. Savage (2005)
10.1161/01.CIR.39.4.449
Digoxin Metabolism in the Elderly
Gordon A Ewy (1969)
10.1016/1043-6618(90)90739-Z
The pharmacokinetics of tricyclic antidepressant drugs in the elderly.
Mario Furlanut (1990)
10.1016/S0193-953X(18)30160-6
Treatment of acute depression.
Elliott Richelson (1993)
10.1016/j.amjcard.2009.04.050
Comparison of outcomes in patients > or =70 years versus <70 years after transradial coronary stenting with maximal antiplatelet therapy for acute coronary syndrome.
Rodrigo Bagur (2009)
10.1161/CIRCULATIONAHA.106.642306
Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions
G. Ndrepepa (2006)
10.1056/NEJMoa066224
Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.
S. Kahn (2006)
10.1046/j.0306-5251.2001.00029.x
The effects of age and renal and hepatic impairment on the pharmacokinetics of sildenafil.
G. Muirhead (2002)
10.1001/archinte.163.22.2705
Hypertension control: how well are we doing?
Ann M. Borzecki (2003)
10.1177/002383099200500109
Lithium-Induced Delirium With Therapeutic Serum Lithium Levels: A Case Report
A. Sutherland Brown (1992)
10.1016/j.amjopharm.2004.12.005
Pharmacokinetics in older persons.
B. Cusack (2004)
10.1136/bmj.2.5267.1647-b
Personal Medical Records
J. Fry (1961)
10.1002/hup.453
Cognitive effects of long-term benzodiazepine use in older adults.
Mary Pat McAndrews (2003)
10.1590/S1516-93322007000100007
Riscos de problemas relacionados com medicamentos em pacientes de uma instituição geriátrica
C. J. Correr (2007)
10.1001/archinte.163.22.2716
Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
D. Fick (2003)



This paper is referenced by
10.1590/S1984-82502014000400018
Potentially inappropriate medication use in institutionalized older adults according to the Beers Criteria
Amanda Rodrigues Ganassin (2014)
SEGUIMENTO FARMACOTERAPÊUTICO A IDOSOS EM UM AMBULATÓRIO
Público De Brasília (2015)
10.5281/zenodo.1206921
Current Trend In Prescribing Pattern Of Antihypertensive Drugs In A Teritiory Care Teaching Hospital: A Prospective Observational Study
Pogula Swathi (2018)
10.5152/tud.2018.25588
Comparison of uropathogens and antibiotic susceptibility patterns in catheterized ambulant middle-aged and elderly Nigerian patients with bladder outlet obstruction.
Patrick Temi Adegun (2018)
10.1002/jcph.699
Pharmacokinetics, Safety, and Tolerability of Metformin in Healthy Elderly Subjects.
Kyungho Jang (2016)
10.1590/S1984-82502013000300006
Pharmacoepidemiological profile and polypharmacy indicators in elderly outpatients
André Oliveira Baldoni (2013)
10.21037/TAU.2018.10.16
Characterizing the pharmacokinetics and pharmacodynamics of immunosuppressant medicines and patient outcomes in elderly renal transplant patients.
A. Cossart (2019)
10.1590/1413-812320152111.14302015
Utilização de medicamentos potencialmente inapropriados por idosos em domicílio
Lázara Montezano Lopes (2016)
A Prospective Study on Prescribing Pattern and Utilization of Anti-Hypertensive Drugs in A Tertiary Care Teaching Hospital
G. Bathula (2016)
10.1590/1413-81232018241.32602016
Factors associated with drug interactions in elderly hospitalized in high complexity hospital.
Ronara Camila de Souza Groia Veloso (2019)
Potentially Inappropriate Medications and their Use in Elderly Populations Residing in Long-Term Care Facilities
Amanda Rodrigues Ganassin (2014)
10.1590/1413-81232018241.32602016
Fatores associados às interações medicamentosas em idosos internados em hospital de alta complexidade
Ronara Camila de Souza Groia Veloso (2019)
Avaliação das prescrições de medicamentos a idosos em um ambulatório de geriatria
Bruna Stephanie Sousa Malaquias (2016)
10.1111/ggi.12999
Potentially inappropriate medications in Chinese older adults: The beers criteria compared with the screening tool of older persons’ prescriptions criteria
H Li (2017)
10.1590/S0080-623420160000100021
[An integrative review of drug utilization by the elderly in primary health care].
Luciane Paula Batista Araújo de Oliveira (2016)
10.1590/1413-812320152111.14302015
Use of potentially inappropriate medications by the elderly at home.
Lázara Montezano Lopes (2016)
10.11606/issn.2176-7262.v49i5p440-450
Evaluation of medications prescribed to in a geriatric outpatient clinic
Bruna Stephanie Sousa Malaquias (2016)
10.1590/0102-311X00128214
Uso de medicamentos potencialmente inadequados entre idosos do Município de Viçosa, Minas Gerais, Brasil: um inquérito de base populacional
Gabriela Aires Martins (2015)
10.3109/14659891.2014.909893
Do medical treatments increase the risk of substance abuse in older people with dementia
Sima Ataollahi Eshkoor (2015)
Avaliação das receitas médicas de pacientes atendidos pelo SUS no município de Sinop-MT : interações medicamentosas e medicamentos inapropriados
Thais Oliveira Gomes (2017)
Semantic Scholar Logo Some data provided by SemanticScholar